SXTC Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 05, 2026
Report Source: 2026 2nd Quarter Report
China SXT Pharmaceuticals Inc. Stock Analysis SXTC
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
Read More China SXT Pharmaceuticals Inc (SXTC) Chart
Key Statistics of China SXT Pharmaceuticals Inc (SXTC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.59Volume
5624.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1.71MAvg. Volume
26.33KDividend Yield
-Financial Metrics & Statements of China SXT Pharmaceuticals Inc (SXTC)
FAQ's for China SXT Pharmaceuticals Inc (SXTC)
- According to Musaffa’s Shariah screening methodology, China SXT Pharmaceuticals Inc (SXTC) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.